Metropolitan Life Insurance Company (MetLife)’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,004	Closed	-$70.5K	–	2257
2024 Q1	$70.5K	Hold	2,004	–	–	﹤0.01%	1238
2023 Q4	$57.9K	Hold	2,004	–	–	﹤0.01%	1365
2023 Q3	$45.9K	Buy	2,004 +341	+21%	+$17.9K	﹤0.01%	1452
2023 Q2	$95.3K	Buy	1,663 +283	+21%	+$14.8K	﹤0.01%	1039
2023 Q1	$51.9K	Sell	1,380 -221	-14%	-$8.14K	﹤0.01%	1367
2022 Q4	$42.8K	Buy	1,601 +214	+15%	+$5.85K	﹤0.01%	1568
2022 Q3	$39.3K	Hold	1,387	–	–	﹤0.01%	1618
2022 Q2	$30.1K	Hold	1,387	–	–	﹤0.01%	1816
2022 Q1	$55.7K	Sell	1,387 -4,491	-76%	-$188K	﹤0.01%	1536
2021 Q4	$279K	Hold	5,878	–	–	﹤0.01%	1784
2021 Q3	$333K	Hold	5,878	–	–	﹤0.01%	1699
2021 Q2	$337K	Buy	5,878 +1,552	+36%	+$85.4K	﹤0.01%	1774
2021 Q1	$274K	Sell	4,326 -253	-6%	-$11.6K	﹤0.01%	1798
2020 Q4	$154K	Hold	4,579	–	–	﹤0.01%	2118
2020 Q3	$125K	Hold	4,579	–	–	﹤0.01%	2089
2020 Q2	$124K	Buy	+4,579	New	+$85.7K	﹤0.01%	2126

Other funds holding MORF

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MORF Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Morphic Holding, Inc. Common Stock (MORF) in Q2 2024, closing a stake of 2,004 shares — an estimated $70.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MORF in Q2 2020 and held it in 16 quarters. The position peaked at $337K in Q2 2021. 136 funds tracked by Wall St. Rank hold MORF as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Morphic Holding, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,004 Morphic Holding, Inc. Common Stock shares in Q2 2024, an estimated $70.5K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Morphic Holding, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
Metropolitan Life Insurance Company (MetLife)'s Morphic Holding, Inc. Common Stock position peaked at $337K in Q2 2021.
136 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.